Markus Peter

Chief Investment Officer at BELLEVUE GROUP AG

Finance

Profile

Mr. Markus Peter is a Head of Investment & Products at Bellevue Asset Management AG.
Mr. Peter previously worked in various functions for Julius Baer Asset Management.
From 1995-2000 he was a Treasury and Specialty Financing Associate for IBM, and from 1990-1995 he worked as an Equity Derivatives Trader for Swiss Bank Union.
Mr. Peter holds a Master's degree in Business Economics from the University of St. Gallen (HSG).

Markus Peter active positions

Companies	Position	Start
BELLEVUE GROUP AG	Chief Investment Officer	2024-02-29
Bellevue Asset Management AG Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.	Portfolio Manager-Equities	2008-12-31

All active positions of Markus Peter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Markus Peter's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BELLEVUE GROUP AG	Finance

Private companies	1
Bellevue Asset Management AG Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.	Finance